av/marksans-pharma--big.svg

NSE:MARKSANS

Marksans Pharma

  • Stock

INR

Last Close

219.39

02/05 08:51

Market Cap

87.17B

Beta: 1.23

Volume Today

1.51M

Avg: 2.09M

PE Ratio

22.85

PFCF: -

Dividend Yield

0.33%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
1.16B
-
1.49B
28.02%
1.79B
20.13%
2.04B
14.06%
2.56B
25.27%
2.68B
4.64%
3.23B
20.76%
4.14B
28.26%
4.55B
9.70%
5.51B
21.28%
7.32B
32.72%
average payables
951.01M
-
1.13B
18.82%
1.40B
24.23%
1.15B
18.34%
867.75M
24.30%
1.05B
21.33%
1.37B
29.73%
1.84B
34.99%
2.15B
16.80%
2.49B
15.83%
2.87B
15.05%
average receivables
921.99M
-
2.14B
132.30%
2.60B
21.55%
3.44B
32.19%
4.15B
20.64%
2.25B
45.91%
4.97B
121.16%
book value per share
9.28
-
11.10
19.63%
10.86
2.14%
11.50
5.91%
13.25
15.21%
15.54
17.24%
21.66
39.38%
29.37
35.62%
42.16
43.54%
46.01
9.14%
54.95
19.41%
capex per share
-0.89
-
-3.22
261.64%
-0.68
78.96%
-0.95
40.31%
-0.32
66.23%
-1.46
353.55%
-1.13
22.14%
-1.13
0.20%
-1.30
14.47%
4.61
455.55%
3.82
17.15%
capex to depreciation
-2.26
-
-4.69
107.44%
-0.92
80.33%
-1.45
57.33%
-0.58
60.26%
-2.24
287.93%
-1.28
42.58%
-1.03
19.43%
-1.03
0.04%
2.81
371.87%
2.07
26.25%
capex to operating cash flow
-0.24
-
-4.28
1,714.21%
-3.14
26.71%
-0.66
78.94%
-0.48
27.38%
-0.28
40.82%
-0.26
8.55%
-0.47
79.71%
-0.23
51.60%
0.91
501.24%
0.84
7.69%
capex to revenue
-0.05
-
-0.15
222.52%
-0.04
75.50%
-0.04
17.94%
-0.01
68.79%
-0.05
296.52%
-0.03
35.74%
-0.03
7.74%
-0.03
7.49%
0.10
431.23%
0.07
31.26%
cash per share
4.53
-
0.86
80.95%
0.61
28.72%
0.97
57.84%
0.80
17.28%
2.28
183.43%
5.16
126.70%
8.47
64.23%
17.37
105.12%
15.45
11.10%
15.56
0.73%
days of inventory on hand
106.61
-
120.16
12.71%
146.99
22.33%
145.23
1.19%
206.83
42.41%
155.32
24.91%
238.57
53.60%
207.11
13.19%
192.03
7.28%
206.12
7.34%
269.83
30.91%
days payables outstanding
87.69
-
85.20
2.84%
125.10
46.83%
44.93
64.09%
74.81
66.51%
67.11
10.29%
99.52
48.29%
97.63
1.90%
91.35
6.43%
89.49
2.04%
97.56
9.02%
days sales outstanding
68.17
-
78.85
15.66%
73.81
6.38%
101.49
37.50%
82.53
18.69%
75.97
7.95%
75.15
1.07%
debt to assets
0.12
-
0.12
0.72%
0.15
19.02%
0.16
10.93%
0.12
22.93%
0.03
73.49%
0.03
16.02%
0.07
143.27%
0.06
16.90%
0.01
80.67%
0.10
815.72%
debt to equity
0.22
-
0.19
10.01%
0.25
26.71%
0.25
1.52%
0.18
26.26%
0.05
74.77%
0.04
17.48%
0.09
139.52%
0.07
23.54%
0.01
80.00%
0.13
826.29%
dividend yield
0.00
-
0.01
244.43%
0.01
20.56%
0.00
76.35%
0.00
135.00%
0.05
1,139.38%
0.00
96.14%
0.01
183.84%
0.00
38.58%
0.00
9.37%
0.00
14.53%
earnings yield
0.04
-
0.04
4.05%
0.00
88.09%
0.02
382.73%
0.08
218.06%
0.21
180.26%
0.12
45.03%
0.10
14.02%
0.09
9.23%
0.04
51.90%
0.04
13.60%
enterprise value
24.31B
-
19.48B
19.84%
20.14B
3.40%
14.62B
27.44%
11.30B
22.73%
5.05B
55.25%
18.69B
269.80%
16.27B
12.96%
26.54B
63.16%
70.03B
163.83%
96.74B
38.14%
enterprise value over ebitda
13.45
-
13.79
2.55%
40.65
194.72%
17.58
56.74%
8.50
51.63%
2.68
68.52%
5.27
97.03%
5.52
4.72%
6.66
20.57%
13.76
106.62%
18.30
33.01%
ev to operating cash flow
15.73
-
63.26
302.12%
227.82
260.15%
24.81
89.11%
41.23
66.20%
2.41
94.16%
10.46
334.35%
16.39
56.73%
11.18
31.78%
30.40
171.85%
46.81
54.01%
ev to sales
3.05
-
2.18
28.51%
2.63
20.40%
1.60
39.01%
1.14
28.57%
0.45
60.88%
1.37
205.20%
1.10
19.54%
1.43
30.39%
3.22
124.42%
3.69
14.68%
free cash flow per share
2.88
-
-2.47
185.62%
-0.46
81.29%
0.49
205.71%
0.35
28.70%
3.67
954.97%
3.23
11.97%
1.29
60.00%
4.44
243.37%
0.48
89.28%
0.74
56.54%
free cash flow yield
0.05
-
-0.05
214.47%
-0.01
81.63%
0.01
247.46%
0.01
7.14%
0.26
1,869.52%
0.06
75.50%
0.03
56.09%
0.06
121.92%
0.00
95.23%
0.00
11.43%
graham net net
-0.91
-
-3.43
275.24%
-4.43
29.23%
-2.44
44.85%
1.63
166.80%
3.65
123.60%
7.28
99.54%
11.01
51.21%
20.54
86.66%
16.63
19.03%
17.27
3.83%
graham number
23.62
-
21.89
7.34%
7.54
65.56%
14.43
91.44%
24.21
67.73%
32.12
32.67%
53.29
65.94%
54.92
3.06%
77.98
41.98%
84.22
8.00%
101.44
20.45%
income quality
1.41
-
0.29
79.59%
0.57
97.53%
1.18
107.79%
0.26
77.80%
1.34
408.59%
0.59
55.72%
0.40
32.21%
0.70
75.33%
0.73
4.46%
0.54
26.07%
intangibles to total assets
0.09
-
0.15
55.39%
0.14
6.78%
0.13
6.36%
0.09
30.12%
0.09
3.37%
0.05
40.78%
0.05
1.01%
0.05
7.63%
0.04
22.05%
0.04
9.78%
interest coverage
17.92
-
16.98
5.28%
3.92
76.91%
7.95
102.68%
18.45
132.24%
32.63
76.81%
91.78
181.29%
46.34
49.50%
37.99
18.02%
69.55
83.07%
96.81
39.20%
interest debt per share
2.22
-
2.32
4.28%
2.78
19.94%
3.04
9.49%
2.59
14.72%
0.85
67.38%
0.92
8.52%
2.84
209.20%
3.19
12.43%
0.89
72.14%
7.36
728.30%
inventory turnover
3.42
-
3.04
11.27%
2.48
18.25%
2.51
1.21%
1.76
29.78%
2.35
33.17%
1.53
34.90%
1.76
15.19%
1.90
7.85%
1.77
6.84%
1.35
23.61%
invested capital
0.22
-
0.19
10.01%
0.25
26.71%
0.25
1.52%
0.18
26.26%
0.05
74.77%
0.04
17.48%
0.09
139.52%
0.07
23.54%
22.70B
32,223,643,785,739.20%
27.36B
20.52%
market cap
25.34B
-
18.95B
25.20%
19.30B
1.84%
13.83B
28.31%
10.62B
23.22%
5.69B
46.44%
20.45B
259.35%
18.62B
8.91%
29.14B
56.47%
71.63B
145.80%
100.57B
40.41%
net current asset value
2.21B
-
1.81B
18.28%
1.82B
0.91%
2.00B
9.79%
2.80B
40.06%
3.42B
22.12%
5.79B
69.17%
7.84B
35.34%
12.50B
59.42%
12.67B
1.40%
14.54B
14.71%
net debt to ebitda
-0.57
-
0.38
166.00%
1.71
353.17%
0.94
44.83%
0.51
46.11%
-0.34
166.27%
-0.49
47.13%
-0.80
61.64%
-0.65
18.57%
-0.31
51.95%
-0.72
131.20%
net income per share
2.67
-
1.92
28.23%
0.23
87.88%
0.80
246.05%
1.97
144.19%
2.95
50.12%
5.83
97.55%
4.56
21.68%
6.41
40.44%
6.92
7.96%
8.40
21.39%
operating cash flow per share
3.77
-
0.75
80.07%
0.22
71.29%
1.44
566.34%
0.67
53.50%
5.13
666.36%
4.37
14.86%
2.42
44.47%
5.74
136.53%
5.08
11.39%
4.56
10.25%
payables turnover
4.16
-
4.28
2.92%
2.92
31.89%
8.12
178.44%
4.88
39.94%
5.44
11.47%
3.67
32.56%
3.74
1.93%
4.00
6.87%
4.08
2.08%
3.74
8.27%
receivables turnover
5.35
-
4.63
13.54%
4.94
6.82%
3.60
27.27%
4.42
22.98%
4.80
8.63%
4.86
1.08%
research and ddevelopement to revenue
0.01
-
return on tangible assets
0.18
-
0.13
28.76%
0.01
88.50%
0.05
253.48%
0.11
112.19%
0.15
34.98%
0.21
38.51%
0.12
41.38%
0.13
5.88%
0.12
4.51%
0.12
0.00%
revenue per share
19.46
-
21.82
12.13%
18.74
14.12%
22.30
18.97%
24.12
8.18%
27.59
14.38%
33.43
21.17%
36.16
8.17%
44.75
23.74%
48.03
7.34%
57.89
20.53%
roe
0.29
-
0.17
40.01%
0.02
87.61%
0.07
226.74%
0.15
111.96%
0.19
28.04%
0.27
41.73%
0.16
42.25%
0.15
2.16%
0.15
0.08%
0.15
1.56%
roic
0.24
-
0.15
37.11%
0.02
85.78%
0.06
190.65%
0.13
108.24%
0.18
40.40%
0.27
45.74%
0.14
49.20%
0.14
2.50%
0.28
97.91%
0.30
9.82%
sales general and administrative to revenue
0.02
-
0.03
4.23%
0.02
9.70%
0.02
3.98%
0.02
32.31%
0.02
9.71%
0.02
4.00%
0.01
-
shareholders equity per share
9.28
-
11.10
19.63%
10.86
2.14%
11.50
5.91%
13.25
15.21%
15.54
17.24%
21.66
39.38%
29.37
35.62%
42.16
43.54%
45.55
8.04%
54.45
19.53%
stock based compensation to revenue
tangible asset value
3.24B
-
3.57B
10.12%
3.48B
2.47%
3.87B
11.21%
4.81B
24.17%
5.66B
17.76%
8.38B
47.99%
11.34B
35.31%
16.56B
45.96%
19.82B
19.68%
23.76B
19.89%
tangible book value per share
9.48
-
11.30
19.29%
11.01
2.56%
9.46
14.07%
11.75
24.17%
13.84
17.76%
20.48
47.99%
27.71
35.31%
40.00
44.34%
43.71
9.28%
52.44
19.95%
working capital
2.23B
-
1.81B
18.82%
1.82B
0.91%
2.16B
18.37%
2.99B
38.43%
3.71B
23.99%
6.04B
62.98%
8.45B
39.93%
13.34B
57.91%
14.73B
10.37%
17.27B
17.26%

All numbers in INR (except ratios and percentages)